Myeloid Derived Suppressor Cells - Cell Biology

Relevant Publications

Impact of high-salt diet in health and diseases and its role in pursuit of cancer immunotherapy by modulating gut microbiome.

Issue Release: 2024

Dual depletion of myeloid-derived suppressor cells and tumor cells with self-assembled gemcitabine-celecoxib nano-twin drug for cancer chemoimmunotherapy.

Issue Release: 2024

Dysfunctional circadian clock accelerates cancer metastasis by intestinal microbiota triggering accumulation of myeloid-derived suppressor cells.

Issue Release: 2024

Functional genetic variants of GEN1 predict overall survival of Chinese epithelial ovarian cancer patients.

Issue Release: 2024

Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export.

Issue Release: 2024

A dual-enzyme-like photosensitive nanozyme for remodeling the tumor immunosuppressive microenvironment to enhance immunotherapy.

Issue Release: 2024

Chemokines and Cytokines in Immunotherapy of Melanoma and Other Tumors: From Biomarkers to Therapeutic Targets.

Issue Release: 2024

Impact of obesity‑associated myeloid‑derived suppressor cells on cancer risk and progression (Review).

Issue Release: 2024

Targeting myeloid-derived suppressor cells by inhibiting hypoxia-inducible factor 1α could improve tumor progression.

Issue Release: 2024

The prognostic implications of cuproptosis-related gene signature and the potential of PPIC as a promising biomarker in cutaneous melanoma.

Issue Release: 2024

Insights of immune cell heterogeneity, tumor-initiated subtype transformation, drug resistance, treatment and detecting technologies in glioma microenvironment.

Issue Release: 2024

Targeting PI3K-gamma in myeloid driven tumour immune suppression: a systematic review and meta-analysis of the preclinical literature.

Issue Release: 2024

Transforming growth factor-β micro-environment mediated immune cell functions in cervical cancer.

Issue Release: 2024

Glioma-derived M-CSF and IL-34 license M-MDSCs to suppress CD8 T cells in a NOS-dependent manner.

Issue Release: 2024

Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.

Issue Release: 2024

Drug-Loaded Mesoporous Silica Nanoparticles Enhance Antitumor Immunotherapy by Regulating MDSCs.

Issue Release: 2024

PPP1R15A-expressing monocytic MDSCs promote immunosuppressive liver microenvironment in fibrosis-associated hepatocellular carcinoma.

Issue Release: 2024

Potential predictors of the pathologic response after neoadjuvant chemoimmunotherapy in resectable non-small cell lung cancer: a narrative review.

Issue Release: 2024

Myeloid-derived suppressor cells in peripheral blood as predictive biomarkers in patients with solid tumors undergoing immune checkpoint therapy: systematic review and meta-analysis.

Issue Release: 2024

Targeting polymorphonuclear myeloid-derived suppressor cells in the immunosuppressive tumor microenvironment for cancer immunotherapy.

Issue Release: 2024

What is Electron Microscopy?

Why Does Chemotherapy Affect Healthy Cells?

How do mitochondria contribute to apoptosis?

How are Ribosomes Assembled?

What are the Advantages of iPSCs?

What is Anabolism?

What is Necrosis?

How Do Agonistic Antibodies Function?

How do cellular processes contribute to neurological disorders?

How Does Fluorescence Microscopy Work?

Myeloid Derived Suppressor Cells - Cell Biology

Relevant Publications

Partnered Content Networks

Relevant Topics